Experience of patients with Parkinson's disease in clinical practice

Grosset, D. (2006) Experience of patients with Parkinson's disease in clinical practice. Round Table Series - Royal Society of Medicine(83), pp. 25-29.

Full text not currently available from Enlighten.

Abstract

Patients should be offered to switch from ergot-derived dopamine agonists to non-ergot-derived dopamine agonists. Where patients remain on these drugs, they should be screened and monitored for fibrotic complications, bearing in mind that the absence of symptoms may be false reassurance. The drugs should be withdrawn if pulmonary fibrosis or cardiac valve disease occurs.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Grosset, Dr Donald
Authors: Grosset, D.
College/School:College of Medical Veterinary and Life Sciences > Institute of Neuroscience and Psychology
Journal Name:Round Table Series - Royal Society of Medicine
Publisher:Royal Society of Medicine
ISSN:0268-3091
Related URLs:

University Staff: Request a correction | Enlighten Editors: Update this record